Viewing Study NCT02561351


Ignite Creation Date: 2025-12-24 @ 11:41 PM
Ignite Modification Date: 2026-01-04 @ 12:23 AM
Study NCT ID: NCT02561351
Status: COMPLETED
Last Update Posted: 2016-05-03
First Post: 2015-09-16
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Correlation Between Fractional Exhaled Nitric Oxide (FeNO) Levels and Asthma Exacerbation
Sponsor: Mahidol University
Organization:

Study Overview

Official Title: Correlation Between Fractional Exhaled Nitric Oxide (FeNO) Levels and Asthma Exacerbation
Status: COMPLETED
Status Verified Date: 2016-05
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: The purpose of this study is to determine mean or median of fractional exhaled nitric oxide (FeNO) in Thai atopic asthmatic children that divided into subgroups due to asthma exacerbation according to the global initiative for asthma guideline.
Detailed Description: From many previous studies, fractional exhaled nitric oxide (FeNO) has many benefits such as non-invasive, easily to perform, less time consume, has direct association with severity of inflammation of bronchial trees and sputum eosinophils, has benefit for diagnosis and monitoring the treatment in asthmatic patients.

In Thailand, this field of study is less extend, especially in children population. The investigators hypothesized that patients with asthma exacerbation may have high level of fractional exhaled nitric oxide (FeNO) than non exacerbation group.

It is therefore desirable to examine the association between fractional exhaled nitric oxide (FeNO) and asthma exacerbation among atopic asthmatic Thai children and will be the main objective of this research.

Study Oversight

Has Oversight DMC: False
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: